These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25237989)

  • 1. Expanding our understanding of respiratory microbiota in cystic fibrosis.
    LiPuma JJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1084-5. PubMed ID: 25237989
    [No Abstract]   [Full Text] [Related]  

  • 2. [New advances in the management and treatment of cystic fibrosis].
    Mihălţan F
    Pneumologia; 2014; 63(1):21-5. PubMed ID: 24800591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three clinically distinct chronic pediatric airway infections share a common core microbiota.
    van der Gast CJ; Cuthbertson L; Rogers GB; Pope C; Marsh RL; Redding GJ; Bruce KD; Chang AB; Hoffman LR
    Ann Am Thorac Soc; 2014 Sep; 11(7):1039-48. PubMed ID: 24597615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.
    Frayman KB; Armstrong DS; Carzino R; Ferkol TW; Grimwood K; Storch GA; Teo SM; Wylie KM; Ranganathan SC
    Thorax; 2017 Dec; 72(12):1104-1112. PubMed ID: 28280235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.
    Tümmler B; Kiewitz C
    Mol Med Today; 1999 Aug; 5(8):351-8. PubMed ID: 10431168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.
    Sherrard LJ; Tunney MM; Elborn JS
    Lancet; 2014 Aug; 384(9944):703-13. PubMed ID: 25152272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis and CRMS screening: what the primary care pediatrician should know.
    Rock MJ; Sharp JK
    Pediatr Ann; 2010 Dec; 39(12):759-68. PubMed ID: 21162484
    [No Abstract]   [Full Text] [Related]  

  • 8. Cystic fibrosis.
    O'Sullivan BP; Freedman SD
    Lancet; 2009 May; 373(9678):1891-904. PubMed ID: 19403164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.
    van Ewijk BE; van der Zalm MM; Wolfs TF; Fleer A; Kimpen JL; Wilbrink B; van der Ent CK
    Pediatrics; 2008 Dec; 122(6):1171-6. PubMed ID: 19047230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonclassic cystic fibrosis: a clinical conundrum.
    Rosenstein BJ
    Pediatr Pulmonol; 2003 Jul; 36(1):10-2. PubMed ID: 12772217
    [No Abstract]   [Full Text] [Related]  

  • 12. Cystic Fibrosis: Emerging Understanding and Therapies.
    Rey MM; Bonk MP; Hadjiliadis D
    Annu Rev Med; 2019 Jan; 70():197-210. PubMed ID: 30312551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiopathogenic and therapeutic aspects of chronic respiratory infection in cystic fibrosis].
    Caramia G; Gagliardini R; Rocchi AL; Palumbo P
    Minerva Pediatr; 1986 Jul; 38(13-14):569-78. PubMed ID: 3528799
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of nonviral vectors for cystic fibrosis gene therapy.
    Alton EW;
    Proc Am Thorac Soc; 2004; 1(4):296-301. PubMed ID: 16113449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis.
    Nurs Times; 2005 May 10-16; 101(19):52. PubMed ID: 15920873
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mucoviscidosis, a challenging medical problem].
    Esedov EM; Gadzhimirzaev GA; Akhmedova FD; Muradova VR; Gadzhimirzaeva RG; Medzhidova RA; Abasova AS
    Vestn Otorinolaringol; 2016; 81(5):15-18. PubMed ID: 27876728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of cystic fibrosis airways disease.
    Boucher RC
    Trans Am Clin Climatol Assoc; 2001; 112():99-107. PubMed ID: 11413787
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of bacterial exacerbations of obstructive lung diseases].
    Kozielski J
    Pol Merkur Lekarski; 2011 Oct; 31(184):201-3. PubMed ID: 22097174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.